|
INN ▲
|
ATC Code ▲
|
Classification ▲
|
Last update ▼
|
|
LABETALOL |
C07AG01 |
II
|
23-11-2023 |
|
MAGNESIUM SULFATE |
B05XA05 |
I
|
23-11-2023 |
|
METAMIZOLE SODIUM |
N02BB02 |
II
|
23-11-2023 |
|
MOXETROL |
G03CB04 |
Currently not available
|
23-11-2023 |
|
NEBIVOLOL AND THIAZIDES |
C07BB12 |
II
|
23-11-2023 |
|
NYSTATIN, COMBINATIONS |
G01AA51 |
I
|
23-11-2023 |
|
OLMESARTAN MEDOXOMIL AND DIURETICS |
C09DA08 |
II
|
23-11-2023 |
|
OMEGA-3-TRIGLYCERIDES INCL. OTHER ESTERS AND ACIDS |
C10AX06 |
Currently not available
|
23-11-2023 |
|
POTASSIUM (DIFFERENT SALTS IN COMBINATION) |
A12BA30 |
Currently not available
|
23-11-2023 |
|
PREDNISOLONE |
H02AB06 |
I
|
23-11-2023 |
|
PROMETHAZINE |
R06AD02 |
I
|
23-11-2023 |
|
RIFAMPICIN AND ISONIAZID |
J04AM02 |
I
|
23-11-2023 |
|
SODIUM CHLORIDE |
B05XA03 |
I
|
23-11-2023 |
|
TERLIPRESSIN |
H01BA04 |
I
|
23-11-2023 |
|
ZINC SULFATE |
A12CB01 |
II
|
23-11-2023 |
|
BOSENTAN |
C02KX01 |
I
|
06-07-2023 |
|
BOSUTINIB |
L01EA04 |
I
|
06-07-2023 |
|
BRINZOLAMIDE |
S01EC04 |
II
|
06-07-2023 |
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
Currently not available
|
06-07-2023 |
|
ERLOTINIB |
L01EB02 |
I
|
06-07-2023 |
|
FERRIC HYDROXIDE |
B03AB04 |
Currently not available
|
06-07-2023 |
|
FERRIC MALTOL |
B03AB10 |
II
|
06-07-2023 |
|
FERRIC PROTEINSUCCINYLATE |
B03AB09 |
II
|
06-07-2023 |
|
FERROUS GLUCONATE |
B03AA03 |
II
|
06-07-2023 |
|
ICATIBANT |
B06AC02 |
I
|
06-07-2023 |
|
IRINOTECAN |
L01CE02 |
I
|
06-07-2023 |
|
IRON, MULTIVITAMINS AND FOLIC ACID |
B03AE02 |
Currently not available
|
06-07-2023 |
|
IRON, MULTIVITAMINS AND MINERALS |
B03AE04 |
Currently not available
|
06-07-2023 |
|
IRON, VITAMIN B12 AND FOLIC ACID |
B03AE01 |
Currently not available
|
06-07-2023 |
|
NILOTINIB |
L01EA03 |
I
|
06-07-2023 |
|
PEGASPARGASE |
L01XX24 |
I
|
06-07-2023 |
|
RAMIPRIL AND AMLODIPINE |
C09BB07 |
II
|
06-07-2023 |
|
RIFAMPICIN |
J04AB02 |
I
|
06-07-2023 |
|
SACCHARATED IRON OXIDE |
B03AB02 |
Currently not available
|
06-07-2023 |
|
SODIUM FEREDETATE |
B03AB03 |
Currently not available
|
06-07-2023 |
|
TEMSIROLIMUS |
L01EG01 |
I
|
06-07-2023 |
|
TOPOTECAN |
L01CE01 |
I
|
06-07-2023 |
|
VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE |
C09DX01 |
II
|
06-07-2023 |
|
VEMURAFENIB |
L01EC01 |
I
|
06-07-2023 |
|
VORICONAZOLE |
J02AC03 |
I
|
06-07-2023 |
|
AZELASTINE |
S01GX07 |
II + Exemption
|
30-11-2022 |
|
CROMOGLICIC ACID |
S01GX01 |
II + Exemption
|
30-11-2022 |
|
EMEDASTINE |
S01GX06 |
II
|
30-11-2022 |
|
EPINASTINE |
S01GX10 |
II
|
30-11-2022 |
|
KETOTIFEN |
S01GX08 |
II + Exemption
|
30-11-2022 |
|
LEVOCABASTINE |
S01GX02 |
II + Exemption
|
30-11-2022 |
|
LIDOCAINE |
D04AB01 |
Not subject to prescription
|
30-11-2022 |
|
LODOXAMIDE |
S01GX05 |
II
|
30-11-2022 |
|
NAPHAZOLINE |
S01GA01 |
Not subject to prescription
|
30-11-2022 |
|
NAPHAZOLINE, COMBINATIONS |
S01GA51 |
Not subject to prescription
|
30-11-2022 |
